Kronos Bio Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. Thanks for joining us. I'm Andrea Tan, biotech analyst at Goldman Sachs, and we're pleased to have with us this morning the team from Kronos. Norbert Bischofberger, President; Yasir Al-Wakeel, CFO; Jorge DiMartino, CMO; and Chris Dinsmore, CSO.
Questions & Answers
With that, Norbert, maybe I'll turn it over to you. And we'd love to hear about the Kronos story, how the company has been evolving as you come up on 1 year almost as a public company?
Thanks, Andrea. And also thanks to Goldman Sachs for having us here today. It's a great pleasure. So Andrea, we were founded only 3 years ago. It's actually amazing, but we have made just incredible progress in these 3 years. We're focused on transcription factors and their associated transcriptional regulatory
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |